Gordon Sussman Clinical Research Incorporated

North York, Ontario M3B 3S6

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Chronic Spontaneous Urticaria

Studies at this site

• A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) — Completed
• Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria — Completed
• A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis — Stopped early